Veracyte Operating Income 2012-2025 | VCYT
Veracyte operating income from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Veracyte Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $16 |
| 2023 | $-86 |
| 2022 | $-41 |
| 2021 | $-82 |
| 2020 | $-35 |
| 2019 | $-15 |
| 2018 | $-22 |
| 2017 | $-27 |
| 2016 | $-29 |
| 2015 | $-33 |
| 2014 | $-29 |
| 2013 | $-23 |
| 2012 | $-19 |
| 2011 | $-15 |
|
Veracyte Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-5 |
| 2025-03-31 | $3 |
| 2024-12-31 | $4 |
| 2024-09-30 | $12 |
| 2024-06-30 | $5 |
| 2024-03-31 | $-5 |
| 2023-12-31 | $-36 |
| 2023-09-30 | $-32 |
| 2023-06-30 | $-8 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-5 |
| 2022-09-30 | $-10 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-12 |
| 2021-09-30 | $-17 |
| 2021-06-30 | $-7 |
| 2021-03-31 | $-45 |
| 2020-12-31 | $-8 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-11 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-8 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-3 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-9 |
| 2017-12-31 | $-6 |
| 2017-09-30 | $-6 |
| 2017-06-30 | $-7 |
| 2017-03-31 | $-8 |
| 2016-12-31 | $-4 |
| 2016-09-30 | $-5 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $-10 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-9 |
| 2015-03-31 | $-8 |
| 2014-12-31 | $-8 |
| 2014-09-30 | $-8 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-7 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-6 |
| 2012-12-31 | |
| 2012-09-30 | $-5 |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.111B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.83 |
| Intuitive Surgical (ISRG) | United States | $196.986B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.663B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.587B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |